Allspring Global Investments Holdings LLC Sells 28,375 Shares of Integer Holdings Co. (NYSE:ITGR)

Allspring Global Investments Holdings LLC decreased its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 14.6% during the 4th quarter, Holdings Channel reports. The firm owned 166,303 shares of the medical equipment provider’s stock after selling 28,375 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Integer were worth $21,980,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in ITGR. Eagle Asset Management Inc. bought a new stake in Integer in the third quarter valued at $14,403,000. Laurus Investment Counsel Inc. acquired a new position in Integer during the 4th quarter worth approximately $5,422,000. Bamco Inc. NY boosted its holdings in Integer by 17.4% in the third quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock worth $33,069,000 after acquiring an additional 37,700 shares in the last quarter. Jane Street Group LLC grew its stake in Integer by 23.3% in the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after acquiring an additional 28,572 shares during the period. Finally, Point72 DIFC Ltd bought a new stake in shares of Integer during the third quarter valued at approximately $2,977,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

Shares of Integer stock opened at $140.94 on Friday. The business’s fifty day simple moving average is $137.84 and its 200 day simple moving average is $131.73. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 12 month low of $94.56 and a 12 month high of $146.36. The firm has a market capitalization of $4.73 billion, a P/E ratio of 43.50, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13.

Wall Street Analysts Forecast Growth

ITGR has been the topic of a number of recent research reports. Benchmark increased their target price on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Truist Financial lifted their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Citigroup lifted their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, KeyCorp increased their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $146.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.